SOURCE: Kadmon Corporation

Kadmon Corporation

November 14, 2013 16:01 ET

Kadmon Corporation to Present at the Jefferies 2013 Global Healthcare Conference

NEW YORK, NY--(Marketwired - Nov 14, 2013) - Kadmon Corporation, LLC today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the Jefferies 2013 Global Healthcare Conference on Wednesday, November 20th at 12:20 p.m. GMT at the Waldorf Hilton in London, UK. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.

A live audio webcast of the presentation will be accessible through Kadmon's website at www.kadmon.com. The webcast will be archived for 90 days.

About Kadmon Corporation
Kadmon Corporation, LLC is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C, and is pioneering novel medicines in areas of serious disease, including oncology, infectious diseases, immunology and neurodegenerative diseases. Emphasizing emerging concepts in molecular biology and genomics, Kadmon is developing treatments and treatment combinations that target the metabolomics and signaling pathways associated with disease, with the goal of addressing some of today's most pressing areas of unmet medical need. For more information, visit www.kadmon.com.

Contact Information

  • Contact Information
    David Pitts
    Argot Partners
    212.600.1902
    Email Contact